<?xml version="1.0" encoding="UTF-8"?>
<p>Moreover, the current literature on the field is still scanty about the clinical aspects of COVID19 in Italian patients. So far, evidence was reported only for individuals having held direct contact with Wuhan.
 <xref rid="jmv25777-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref> Death rates from pulmonary infectious agents account for about 11% to 14%, usually involving people aged 75 to 90 years, therefore the current estimation of about 2.83% to 3.6% of deaths caused by COVID19, may appear limited respect to the big claim burst on the SARS‐CoV2 infection. Furthermore, the biggest concern currently forwarded by media regards the SARS‐CoV2 impact on the resuscitation units of the many health care structures in Italy. This may appear controversial with the number of patients with confirmed pulmonary pathology undergoing hospitalization. During the 2002‐SARS epidemics evidence that transmission may occur during cardiopulmonary resuscitation was reported but did not raise particular concern.
 <xref rid="jmv25777-bib-0017" ref-type="ref">
  <sup>17</sup>
 </xref> Therefore, the Italian authorities engaged to face at the SARS‐CoV2 outbreak should inform citizens also about the stratified number of hospitalized people in the resuscitation units, to have a cleared overview of the SARS‐CoV2 epidemics in our country.
</p>
